펨테크 시장 : 기술별, 용도별, 최종사용자별, 지역별, 기회, 예측(2017-2031년)

Global FemTech market is projected to witness a CAGR of 13.58% during the forecast period 2024-2031, growing from USD 56.16 billion in 2023 to USD 155.54 billion in 2031. FemTech market is a technology-driven concept aimed at monitoring women's health and well-being. The rising demand for personalized healthcare significantly influences the FemTech market, reshaping the landscape of women's health technology in many ways. The surge in demand for personalized healthcare has led to substantial investments in FemTech startups. For instance, Laiqa Wellness Private Limited, India, a Gurgaon-based FemTech startup offering personalized health tech solutions, has raised USD 1.8 million (INR 15 crore) in seed funding from IvyCap Ventures to scale the business. Furthermore, the changing modern lifestyle of women is a significant driver of demand for FemTech market. As women are continuously seeking demanding positions in the corporate sector and busy lifestyles, they often face time constraints that hinder their self-care, resulting in unhealthy lifestyles and reduced physical activity. This accelerated pace of life has led to a surge in health issues, such as reproductive health challenges, stress, and chronic conditions like obesity and cardiovascular diseases. FemTech solutions are designed to address these concerns by providing targeted, personalized healthcare options.

Growing Impact of Chronic and Infectious Diseases on Women Fuels Market Growth

The growing impact of chronic and infectious diseases on women is substantially fueling the growth of the FemTech market. Health challenges for women, such as reproductive disorders, autoimmune diseases, and even infectious conditions, have created a significant requirement for innovative solutions to cater to women's health issues. For instance, according to BioMed Central Limited, around 512 out of every 1,000 women are affected by a single chronic condition, while 258 per 1,000 have two or more chronic conditions. The occurrence of multiple chronic conditions is particularly prevalent among senior female demographics. The rising demand for women's health solutions has created favorable conditions for the proliferation of FemTech startups and technologies. Services ranging from telemedicine to wearable health devices have already gained immense popularity in this sector. These technologies empower women to address physical and mental health-related issues, ultimately giving them greater control over their health and contributing to improved quality of life's outcomes. As awareness of health issues continues to grow among women, so do the opportunities offered by FemTech to revolutionize women's healthcare all across the globe.

Rapid Development of Technologies is Driving the Market

New technologies are rapidly driving the growth of FemTech market, focusing increasingly on digital health solutions and wearable devices to meet the unique needs of women. Mobile health applications, telehealth platforms, and data analytics innovations empower women to monitor their health more effectively and receive personalized support. For instance, in August 2024, Motherbeing, a FemTech company based in Egypt, introduced a new mobile app called Daleela. This app leverages AI technology to give Arab women secure and private access to information and personalized support regarding their sexual and reproductive health. Available on both iOS and Android, Daleela provides a platform where women can interact with an AI assistant for customized guidance on various topics, including menstruation, sexual health, and fertility.

While these technologies offer the chance to add convenience to women's lives, they also open up much wider acceptance of women's health issues, thereby facilitating earlier interventions for conditions such as menstrual disorders, pregnancy-related issues, and menopause. Moreover, incorporating artificial intelligence and machine learning into FemTech solutions is anticipated to trigger greater precision in diagnostics and treatment options. The transformation of women's healthcare by technology holds promise for the near future regarding affordability, efficiency, and user-friendliness.

Changing Demographics Significantly Impact the Market

Changing demographics significantly influence the FemTech market by creating a diverse health needs and preferences landscape. The aging population is leading the inquiries for menopause and chronic health issues, whereas the younger generations, with millennials and Gen Z on the front line, place value on health, wellness, and convenience, pushing forward innovation in technology and services.

Moreover, the rise in diverse identities and experiences has caused the demand for products that are targeted to many different women's health concerns, including those of LGBTQ+ communities and women of color. The growing number of women in the workforce has also heightened the demand for flexible health solutions such as telehealth services and mobile apps. For instance, the Periodic Labour Force Survey Report 2022-23, released by the Ministry of Statistics and Programme Implementation in India on October 9, 2023, indicates a notable increase in the Female Labour Force Participation Rate. It rose by 4.2% points to reach 37.0% in 2023, based on the 'usual status' method of measuring labor force participation. Globalization is exposing women to new health trends and practices, and changing demographics are opening the doors for the development of FemTech products and services that align with the changing needs of women today.

North America is Holding Significant Share of the Market

North America predominantly leads the FemTech market for several reasons; the region has experienced substantial venture capital funding in startups within the FemTech space, encouraging innovation and new technologies. Additionally, increased educational or advocacy efforts on supporting women's health issues have created the demand for health solutions that are addressed specifically to women's health problems. For instance, in August 2024, Flo Health Inc. secured over USD 200 million in investment from General Atlantic Private Limited, elevating its valuation to over USD 1 billion and making it the first purely digital women's health app to achieve unicorn status. Committed to supporting women throughout their health journeys from menstruation to conception, pregnancy, and menopause, Flo offers an all-in-one platform that includes curated cycle and ovulation tracking backed by a team of more than 120 doctors and health experts.

Further, North America consists of females with relatively higher internet and tech adoption, driving various FemTech solutions, such as health tracking apps or telehealth services. The Regulatory environment is perceived to be relatively supportive of new product development and market entry, with a diverse consumer base seeking personalized solutions that are often highly functional. The region benefits from sophisticated healthcare systems that provide a platform for health technology researchers, developers, and providers to work together. Additionally, with the growth of feminism among women and a focus on health and well-being, it is indicative that more FemTech solutions will see light in this region, thus marking itself as an epicenter in the region's level playing field.

Future Market Scenario (2024-2031F)

The growth of FemTech market accelerating due to the increasing prevalence of chronic and infectious diseases among women. Consequently, the demand for tailored health solutions is expected to drive the growth of FemTech market.

Furthermore, the rapid advancements in digital health technologies, coupled with the increasing demand for improved access to personalized care, are anticipated to drive significant growth in the FemTech market.

Additionally, demographic shifts, such as aging population and a younger workforce, are creating diverse healthcare needs and solutions fueling the FemTech market growth. Also, growing venture capital investments further propel the emergence of new FemTech startups and technologies, thereby driving FemTech market demand.

North America region is anticipated to hold significant position in the FemTech market, due to the higher internet adoption among women, in addition to developed healthcare infrastructure.

Key Players Landscape and Outlook

The FemTech market is fragmented, with various startups addressing various aspects of women's health, including reproductive, maternal, menstrual, and sexual wellness. Many FemTech companies are forming strategic partnerships with healthcare providers, pharmaceutical firms, and research institutions to navigate this landscape, enhancing their credibility and fostering innovation. For instance, in July 2024, Femtech Insider, a leading global platform for women's health innovation, partnered with Proem, an AI-powered research dissemination platform, to enhance access to the latest research in women's health for a broader and more diverse audience. Announced at TechBBQ in Copenhagen, this partnership represents a crucial advancement in closing the gender health research gap and democratizing scientific knowledge related to women's health.

Also, in September 2024, Zepp Health Corporation, a global leader in smart wearables and health technology, announced a significant integration with Wild.AI, a wellness app designed for women. This collaboration introduces Wild.AI's advanced health and wellness features directly on Amazfit smartwatches, beginning with the Amazfit Active series. This makes the Amazfit Active the first smartwatch to incorporate Wild.AI, specifically addressing female physiology and training needs. The integration will also be extended to other Amazfit series, providing female users with advanced health management solutions at no additional cost.

Additionally, the sector is experiencing significant investment growth as venture capitalists increasingly recognize the potential of addressing women's health issues, often focusing on sustainable practices and social impact. For instance, In July 2024, Kindred Health Inc., a FemTech company based in the Philippines, announced that it had completed its pre-Series A funding round, securing a total of USD 5.5 million.

This influx of funding supports the launch of new startups and the development of innovative solutions, further driving the evolution of the FemTech market. For instance, in August 2024, Gurugram-based FemTech startup Laiqa Wellness secured INR 15 crore seed funding from IvyCap Ventures. The funds will enhance and expand the company's technology-driven solutions, focusing on personalized hormonal health tracking, point-of-care assessments, and AI-driven recommendations combining modern science with Ayurveda. All these instances reflect the promising future landscape of the FemTech Market.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Voice of Customer

• 4.1. Product and Market Intelligence
• 4.2. Mode of Brand Awareness
• 4.3. Factors Considered in Purchase Decisions
  • 4.3.1. Features and Other Value-Added Service
  • 4.3.2. IT Infrastructure Compatibility
  • 4.3.3. Efficiency of Solutions
  • 4.3.4. After-Sales Support
• 4.4. Consideration of Privacy and Regulations

5. Global FemTech Market Outlook, 2017-2031F

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Technology
    • 5.2.1.1. Mobile Applications
    • 5.2.1.2. Wearable Technology
    • 5.2.1.3. Telemedicine Solutions
    • 5.2.1.4. Artificial Intelligence
  • 5.2.2. By Applications
    • 5.2.2.1. Maternal and Infant Digital Solutions
    • 5.2.2.2. Prenatal Diagnostics
    • 5.2.2.3. Breast Imaging Systems
    • 5.2.2.4. Urology Diagnostics
    • 5.2.2.5. Oncology Diagnostics
    • 5.2.2.6. Cardiology Diagnostics
  • 5.2.3. By End-user
    • 5.2.3.1. Hospitals
    • 5.2.3.2. Fertility Clinics
    • 5.2.3.3. Surgical Centers
    • 5.2.3.4. Diagnostic Centers
    • 5.2.3.5. Other
  • 5.2.4. By Region
    • 5.2.4.1. North America
    • 5.2.4.2. Europe
    • 5.2.4.3. Asia-Pacific
    • 5.2.4.4. South America
    • 5.2.4.5. Middle East and Africa
  • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
• 5.3. Market Map Analysis, 2023
  • 5.3.1. By Technology
  • 5.3.2. By Application
  • 5.3.3. By End-User
  • 5.3.4. By Region

6. North America FemTech Market Outlook, 2017-2031F*

• 6.1. Market Size Analysis & Forecast
  • 6.1.1. By Value
• 6.2. Market Share Analysis & Forecast
  • 6.2.1. By Technology
    • 6.2.1.1. Mobile Applications
    • 6.2.1.2. Wearable Technology
    • 6.2.1.3. Telemedicine Solutions
    • 6.2.1.4. Artificial Intelligence
  • 6.2.2. By Applications
    • 6.2.2.1. Maternal and Infant Digital Solutions
    • 6.2.2.2. Prenatal Diagnostics
    • 6.2.2.3. Breast Imaging Systems
    • 6.2.2.4. Urology Diagnostics
    • 6.2.2.5. Oncology Diagnostics
    • 6.2.2.6. Cardiology Diagnostics
  • 6.2.3. By End-user
    • 6.2.3.1. Hospitals
    • 6.2.3.2. Fertility Clinics
    • 6.2.3.3. Surgical Centers
    • 6.2.3.4. Diagnostic Centers
    • 6.2.3.5. Other
  • 6.2.4. By Country Share
    • 6.2.4.1. United States
    • 6.2.4.2. Canada
    • 6.2.4.3. Mexico
• 6.3. Country Market Assessment
  • 6.3.1. United States FemTech Market Outlook, 2017-2031F*
    • 6.3.1.1. Market Size Analysis & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share Analysis & Forecast
      • 6.3.1.2.1. By Technology
        • 6.3.1.2.1.1. Mobile Applications
        • 6.3.1.2.1.2. Wearable Technology
        • 6.3.1.2.1.3. Telemedicine Solutions
        • 6.3.1.2.1.4. Artificial Intelligence
      • 6.3.1.2.2. By Applications
        • 6.3.1.2.2.1. Maternal and Infant Digital Solutions
        • 6.3.1.2.2.2. Prenatal Diagnostics
        • 6.3.1.2.2.3. Breast Imaging Systems
        • 6.3.1.2.2.4. Urology Diagnostics
        • 6.3.1.2.2.5. Oncology Diagnostics
        • 6.3.1.2.2.6. Cardiology Diagnostics
      • 6.3.1.2.3. By End-User
        • 6.3.1.2.3.1. Hospitals
        • 6.3.1.2.3.2. Fertility Clinics
        • 6.3.1.2.3.3. Surgical Centers
        • 6.3.1.2.3.4. Diagnostic Centers
        • 6.3.1.2.3.5. Other
  • 6.3.2. Canada
  • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe FemTech Market Outlook, 2017-2031F

• 7.1. Germany
• 7.2. France
• 7.3. Italy
• 7.4. United Kingdom
• 7.5. Russia
• 7.6. Netherlands
• 7.7. Spain
• 7.8. Turkey
• 7.9. Poland

8. Asia-Pacific FemTech Market Outlook, 2017-2031F

• 8.1. India
• 8.2. China
• 8.3. Japan
• 8.4. Australia
• 8.5. Vietnam
• 8.6. South Korea
• 8.7. Indonesia
• 8.8. Philippines

9. South America FemTech Market Outlook, 2017-2031F

• 9.1. Brazil
• 9.2. Argentina

10. Middle East and Africa FemTech Market Outlook, 2017-2031F

• 10.1. Saudi Arabia
• 10.2. UAE
• 10.3. South Africa

11. Porter's Five Forces Analysis

12. PESTLE Analysis

13. Market Dynamics

• 13.1. Market Drivers
• 13.2. Market Challenges

14. Market Trends and Developments

15. Case Studies

16. Competitive Landscape

• 16.1. Competition Matrix of Top 5 Market Leaders
• 16.2. SWOT Analysis for Top 5 Players
• 16.3. Key Players Landscape for Top 10 Market Players
  • 16.3.1. Biowink GmbH
    • 16.3.1.1. Company Details
    • 16.3.1.2. Key Management Personnel
    • 16.3.1.3. Products and Services
    • 16.3.1.4. Financials (As Reported)
    • 16.3.1.5. Key Market Focus and Geographical Presence
    • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 16.3.2. Flo Health Inc.
  • 16.3.3. HeraMED Limited
  • 16.3.4. NaturalCycles USA Corporation
  • 16.3.5. Astrid Health, Inc.
  • 16.3.6. NUVO Inc.
  • 16.3.7. Bloomlife Inc
  • 16.3.8. Athena Feminine Technologies, Inc.
  • 16.3.9. iSono Health, Inc.
  • 16.3.10. Samplytics Technologies Private Limited

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer